Analyst Price Targets — BIO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 25, 2026 9:06 am | — | Wells Fargo | $310.00 | $287.74 | TheFly | Bio-Rad price target raised to $310 from $290 at Wells Fargo |
| May 14, 2026 8:24 pm | — | RBC Capital | $320.00 | $246.27 | TheFly | Bio-Rad resumed with an Outperform at RBC Capital |
| May 1, 2026 10:27 am | — | Wells Fargo | $290.00 | $280.12 | TheFly | Bio-Rad price target lowered to $290 from $320 at Wells Fargo |
| February 16, 2026 12:43 pm | Brandon Couillard | Wells Fargo | $320.00 | $256.56 | TheFly | Bio-Rad price target lowered to $320 from $340 at Wells Fargo |
| February 13, 2026 2:33 pm | — | UBS | $335.00 | $259.64 | TheFly | Bio-Rad price target lowered to $335 from $350 at UBS |
| October 30, 2025 10:28 am | — | Wells Fargo | $340.00 | $319.47 | TheFly | Bio-Rad price target raised to $340 from $265 at Wells Fargo |
| October 1, 2024 5:34 am | Patrick Donnelly | Citigroup | $400.00 | $338.58 | StreetInsider | Citi Upgrades Bio-Rad Labs (BIO) to Buy |
| December 7, 2022 4:42 am | — | RBC Capital | $565.00 | $399.59 | Benzinga | RBC Capital Initiates Coverage On Bio-Rad Laboratories with Outperform Rating, Announces Price Target of $565 |
Latest News for BIO
VANCOUVER, BC, Canada – TheNewswire - July 17, 2026 — Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) (“Noveris” or the “Company”) is pleased to announce that it has joined the Biotechnology Innovation Organization (“BIO”), the world's largest advocacy association representing biotechnology companies, academic and research institutions, state and regional biotechnology centers and related…
HOLMDEL, N.J., July 07, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that The Nasdaq Stock Market LLC has notified it that the trading of its common stock will recommence on the Nasdaq Capital Market effective with markets' opening on Wednesday, July 8, 2026.
New Taipei City, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced its participation in the BIO International Convention (BIO 2026), held in San Diego, California, from June 22 to June 25, 2026.
BIO-key (BKYI) a global leader in biometric-powered identity & access management to participate at Jordan Banking Cybersecurity Workshop in Amman, July 6.
I assign a "Buy" rating to Bio-Rad Laboratories, citing activist involvement. Elliott's entry signals meaningful re-rating potential, assuming further operational improvements; BIO is already shifting M&A focus to revenue-generating bolt-ons and rationalizing R&D spend. The potential monetization of BIO's Sartorius stake, worth over $5 billion, appears more likely with Elliott's involvement, since the activist is…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.